CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma. [electronic resource]
Producer: 20201005Description: 11-19 p. digitalISSN:- 1744-8301
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Agents, Immunological -- administration & dosage
- Carcinoma, Squamous Cell -- diagnosis
- Clinical Protocols
- Female
- Humans
- Male
- Molecular Targeted Therapy
- Neoplasm Metastasis
- Neoplasm Staging
- Prognosis
- Skin Neoplasms -- diagnosis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.